LAVA Therapeutics N.V. (LVTX)

LAVA Therapeutics Revenue

LAVA Therapeutics had revenue of $7.40M in the twelve months ending June 30, 2024, down -69.51% year-over-year. In the year 2023, LAVA Therapeutics had annual revenue of $6.77M, down -65.09%.

• Revenue (ttm): $7.40M
• Revenue Growth: -69.51%
• P/S Ratio: 6.71
• Revenue / Employee: $199,946
• Employees: 37
• Market Cap: 48.39M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	6.77M	-12.62M	-65.09%
Dec 31, 2022	19.39M	14.04M	262.45%
Dec 31, 2021	5.35M	1.60M	42.78%
Dec 31, 2020	3.75M	-	-
Jan 1, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.